×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
WINT – windtree therapeutics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
WINT
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/3
09:00 am
wint
Windtree Therapeutics Announces It Has Signed a Letter of Intent to Acquire CommLoan, Inc. a Revenue Generating Company in the Rapidly Growing Fintech Space
High
Report
Windtree Therapeutics Announces It Has Signed a Letter of Intent to Acquire CommLoan, Inc. a Revenue Generating Company in the Rapidly Growing Fintech Space
11/17
09:12 am
wint
Windtree Therapeutics Announces It May Receive License Agreement Payments from Its Licensee for Renewed Acute Pulmonary Development by the Licensee [Yahoo! Finance]
Neutral
Report
Windtree Therapeutics Announces It May Receive License Agreement Payments from Its Licensee for Renewed Acute Pulmonary Development by the Licensee [Yahoo! Finance]
11/17
09:00 am
wint
Windtree Therapeutics Announces It May Receive License Agreement Payments from Its Licensee for Renewed Acute Pulmonary Development by the Licensee
Medium
Report
Windtree Therapeutics Announces It May Receive License Agreement Payments from Its Licensee for Renewed Acute Pulmonary Development by the Licensee
11/14
09:18 am
wint
Windtree Therapeutics Announces More Strengthening of Its Istaroxime and Next Generation SERCA2a activator Patent Estate [Yahoo! Finance]
Medium
Report
Windtree Therapeutics Announces More Strengthening of Its Istaroxime and Next Generation SERCA2a activator Patent Estate [Yahoo! Finance]
11/14
09:00 am
wint
Windtree Therapeutics Announces More Strengthening of Its Istaroxime and Next Generation SERCA2a activator Patent Estate
High
Report
Windtree Therapeutics Announces More Strengthening of Its Istaroxime and Next Generation SERCA2a activator Patent Estate
11/13
01:30 pm
wint
Windtree Therapeutics Announces It Will Receive $7.5 Million In Cash and Securities from the Recently Executed Termination Agreement with an Environmental Services Company [Yahoo! Finance]
Low
Report
Windtree Therapeutics Announces It Will Receive $7.5 Million In Cash and Securities from the Recently Executed Termination Agreement with an Environmental Services Company [Yahoo! Finance]
11/13
09:00 am
wint
Windtree Therapeutics Announces It Will Receive $7.5 Million In Cash and Securities from the Recently Executed Termination Agreement with an Environmental Services Company
High
Report
Windtree Therapeutics Announces It Will Receive $7.5 Million In Cash and Securities from the Recently Executed Termination Agreement with an Environmental Services Company
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/2
04:31 pm
wint
Form 8-K WINDTREE THERAPEUTICS For: Nov 25
High
Report
Form 8-K WINDTREE THERAPEUTICS For: Nov 25
11/21
08:16 am
wint
Form 424B3 WINDTREE THERAPEUTICS
High
Report
Form 424B3 WINDTREE THERAPEUTICS
11/19
05:02 pm
wint
Form 10-Q WINDTREE THERAPEUTICS For: Sep 30
Low
Report
Form 10-Q WINDTREE THERAPEUTICS For: Sep 30
11/14
04:17 pm
wint
Form NT 10-Q WINDTREE THERAPEUTICS For: Sep 30
Medium
Report
Form NT 10-Q WINDTREE THERAPEUTICS For: Sep 30
11/13
08:02 am
wint
Form 424B3 WINDTREE THERAPEUTICS
High
Report
Form 424B3 WINDTREE THERAPEUTICS
10/24
04:09 pm
wint
Form S-1 WINDTREE THERAPEUTICS
Medium
Report
Form S-1 WINDTREE THERAPEUTICS
10/16
05:05 pm
wint
Form 8-K WINDTREE THERAPEUTICS For: Oct 09
Low
Report
Form 8-K WINDTREE THERAPEUTICS For: Oct 09
10/6
02:27 pm
wint
Form 8-K WINDTREE THERAPEUTICS For: Oct 06
Low
Report
Form 8-K WINDTREE THERAPEUTICS For: Oct 06
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/24
Windtree to Pursue Clinical Study of Lung Injury Treatment in COVID-19 Patients with its KL4 Surfactant Therapy
59.5%
11/14 Q3/2019 9/30/2019 EPS -0.220 ZacksConsensus N/A ActVsEst N/A - N/A 37.4%
12/9 Windtree Therapeutics Completes $26.4 Million Private Placement 29.4%
5/17 Form NT 10-Q/A WINDTREE THERAPEUTICS For: Mar 31 21.2%
10/25 Windtree Therapeutics Provides Business Update 17.2%
5/31 Form 8-K WINDTREE THERAPEUTICS For: May 30 7.1%
1/27 Form S-1 WINDTREE THERAPEUTICS 6.9%
1/21 Form S-1 WINDTREE THERAPEUTICS 6.2%
4/2 Q4/2019 12/31/2019 EPS -0.210 ZacksConsensus N/A ActVsEst N/A - N/A 3.1%
1/3 Form 4 WINDTREE THERAPEUTICS For: Dec 31 Filed by: Huang James 2.4%
11/14 Q3/2019 9/30/2019 EPS -0.220 ZacksConsensus N/A ActVsEst N/A - N/A 37.4%
12/9 Windtree Therapeutics Completes $26.4 Million Private Placement 29.4%
5/17 Form NT 10-Q/A WINDTREE THERAPEUTICS For: Mar 31 21.2%
10/25 Windtree Therapeutics Provides Business Update 17.2%
5/31 Form 8-K WINDTREE THERAPEUTICS For: May 30 7.1%
1/27 Form S-1 WINDTREE THERAPEUTICS 6.9%
1/21 Form S-1 WINDTREE THERAPEUTICS 6.2%
4/2 Q4/2019 12/31/2019 EPS -0.210 ZacksConsensus N/A ActVsEst N/A - N/A 3.1%
1/3 Form 4 WINDTREE THERAPEUTICS For: Dec 31 Filed by: Huang James 2.4%
TOP News Decliners
3/23
Form 8-K WINDTREE THERAPEUTICS For: Mar 18
-33.3%
1/21 Form 4 WINDTREE THERAPEUTICS For: Jan 16 Filed by: Huang James -18.9%
2/4 Windtree Therapeutics Inc (OTCMKTS: WINT) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. -13.6%
4/24 Form 8-K WINDTREE THERAPEUTICS For: Apr 20 -7.6%
2/20 Form 4 WINDTREE THERAPEUTICS For: Feb 18 Filed by: Huang James -7.3%
3/30 Form NT 10-K WINDTREE THERAPEUTICS For: Dec 31 -4.5%
7/17 Form PRER14C WINDTREE THERAPEUTICS -4.0%
12/9 Form 8-K WINDTREE THERAPEUTICS For: Dec 09 -2.7%
12/20 Form SC 13D/A WINDTREE THERAPEUTICS Filed by: LPH II Investments Ltd -1.4%
2/7 Form 4 WINDTREE THERAPEUTICS For: Feb 07 Filed by: Huang James -1.2%
1/21 Form 4 WINDTREE THERAPEUTICS For: Jan 16 Filed by: Huang James -18.9%
2/4 Windtree Therapeutics Inc (OTCMKTS: WINT) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. -13.6%
4/24 Form 8-K WINDTREE THERAPEUTICS For: Apr 20 -7.6%
2/20 Form 4 WINDTREE THERAPEUTICS For: Feb 18 Filed by: Huang James -7.3%
3/30 Form NT 10-K WINDTREE THERAPEUTICS For: Dec 31 -4.5%
7/17 Form PRER14C WINDTREE THERAPEUTICS -4.0%
12/9 Form 8-K WINDTREE THERAPEUTICS For: Dec 09 -2.7%
12/20 Form SC 13D/A WINDTREE THERAPEUTICS Filed by: LPH II Investments Ltd -1.4%
2/7 Form 4 WINDTREE THERAPEUTICS For: Feb 07 Filed by: Huang James -1.2%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: